Product Information
CARBIDOPA-LEVODOPA 25-250 TAB is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1112 per EA under NDC 00093970305. Its NADAC has been published 120 times since Mar 20, 2024.
Strength
25; 250 mg/1; mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093970305
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARBIDOPA HYDRATE; LEVODOPAApproval Type
Generic (ANDA)
FDA Application
ANDA074260On Market Since
12/15/2023
Pharmacological Classes
Price Statistics
The NADAC for CARBIDOPA-LEVODOPA 25-250 TAB has been published 120 times since Mar 20, 2024, and over the history we have for it it has declined 18.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1112 per EA |
|---|---|
| All-time high | $0.1424 (Oct 16, 2024) |
| All-time low | $0.0731 (Apr 17, 2024) |
| 52-week high | $0.1403 |
| 52-week low | $0.1104 |
| Median price | $0.1275 |
| Average price | $0.1208 |
| Largest weekly change | +71.8% (Jun 19, 2024) |
| Weeks tracked | 120 |
| Tracking since | Mar 20, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARBIDOPA-LEVODOPA 25-250 TAB?
The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVODOPA 25-250 TAB, manufactured by Teva Pharmaceuticals USA Inc., is $0.1112 per EA (NDC 00093970305), effective Jul 1, 2026.
How has the price of CARBIDOPA-LEVODOPA 25-250 TAB changed over time?
Over the history we have for it, the NADAC for CARBIDOPA-LEVODOPA 25-250 TAB has declined 18.7%. It has been tracked across 120 weekly CMS publications since Mar 20, 2024.
What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVODOPA 25-250 TAB?
Since Mar 20, 2024, the NADAC for CARBIDOPA-LEVODOPA 25-250 TAB has ranged from a low of $0.0731 (Apr 17, 2024) to a high of $0.1424 (Oct 16, 2024), with a median of $0.1275 per EA.
Are there cheaper alternatives to CARBIDOPA-LEVODOPA 25-250 TAB?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CARBIDOPA-LEVODOPA 25-250 TAB, is $0.1104 per EA — about 1% below CARBIDOPA-LEVODOPA 25-250 TAB.
Who manufactures CARBIDOPA-LEVODOPA 25-250 TAB?
CARBIDOPA-LEVODOPA 25-250 TAB (NDC 00093970305) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification